Suppr超能文献

宫颈上皮内瘤变保守治疗后发生的浸润性宫颈癌。

Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia.

作者信息

Soutter W P, de Barros Lopes A, Fletcher A, Monaghan J M, Duncan I D, Paraskevaidis E, Kitchener H C

机构信息

Institute of Obstetrics and Gynaecology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

出版信息

Lancet. 1997 Apr 5;349(9057):978-80. doi: 10.1016/s0140-6736(96)08295-5.

Abstract

BACKGROUND

Conservative outpatient therapy for cervical intraepithelial neoplasia (CIN) by ablative or excisional techniques is widely used. The main objective of this treatment is the prevention of invasive cervical cancer. We assessed the rate of invasive disease and the duration of the risk of developing invasive cervical cancer after such treatment.

METHODS

Four UK centres have used life-table methods to analyse the long-term results of conservative treatment of CIN. We combined and updated data from these studies to investigate the rate of invasive disease after treatment and the duration of that risk.

FINDINGS

The data comprised 44 699 woman-years of follow-up, with 2116 women under observation 8 years after treatment. 33 women developed invasive cancer, 14 of whom had microinvasion. The cumulative rate of invasion 8 years after treatment was 5.8 per 1000 women and the rate of invasive cancer during this period was 85 (95% CI 60-119) per 100,000 woman-years. The risk of developing cancer did not change throughout the 8 years of follow-up.

INTERPRETATION

These data show that conservative outpatient therapy in women with CIN reduces the risk of invasive cancer of the cervix by 95% during the first 8 years after treatment. However, even with careful, long-term follow-up, the risk of invasive cervical cancer among these women is about five times greater than that among the general population of women throughout that period. Careful follow-up is essential for at least 10 years after conservative treatment of CIN.

摘要

背景

通过消融或切除技术对宫颈上皮内瘤变(CIN)进行保守的门诊治疗被广泛应用。这种治疗的主要目的是预防浸润性宫颈癌。我们评估了这种治疗后浸润性疾病的发生率以及发生浸润性宫颈癌风险的持续时间。

方法

英国的四个中心采用寿命表法分析CIN保守治疗的长期结果。我们合并并更新了这些研究的数据,以调查治疗后浸润性疾病的发生率以及该风险的持续时间。

结果

数据包括44699人年的随访,2116名女性在治疗后8年接受观察。33名女性发生浸润癌,其中14名有微浸润。治疗后8年的累积浸润率为每1000名女性中有5.8例,在此期间浸润癌的发生率为每100000人年85例(95%可信区间60 - 119)。在整个8年的随访期间,患癌风险没有变化。

解读

这些数据表明,CIN女性的保守门诊治疗在治疗后的前8年将浸润性宫颈癌的风险降低了95%。然而,即使进行仔细的长期随访,在此期间这些女性发生浸润性宫颈癌的风险仍比普通女性人群高约五倍。CIN保守治疗后至少10年的仔细随访至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验